NCT00138281View on ClinicalTrials.gov

Influenza Immunity Against Pandemic Respiratory Virus

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

Not specified

Primary Completion Date

November 30, 2005

Study Completion Date

January 31, 2006

Conditions
Influenza
Interventions
BIOLOGICAL

FluMist

BIOLOGICAL

Fluzone

Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00138281 - Influenza Immunity Against Pandemic Respiratory Virus | Biotech Hunter | Biotech Hunter